Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Type 2 Diabetes Mellitus 1”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT00142922
What this trial is testing

Breaking Down Barriers to Diabetes Self-Care

Who this might be right for
Type 1 DiabetesType 2 Diabetes
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 222
Not applicableUnknownNCT05990374
What this trial is testing

Therapeutic Effects and Effects on Body Fat of GLP-1 Receptor Agonists in Patients With Type 2 Diabetes for 1-4 Years

Who this might be right for
Diabetes
Nanjing First Hospital, Nanjing Medical University 100
Not applicableWithdrawnNCT04667182
What this trial is testing

Glucose Control in Participants With Type 1 and Type 2 Diabetes

Who this might be right for
Type 1 DiabetesType 2 Diabetes
Eli Lilly and Company
Not applicableStudy completedNCT01492959
What this trial is testing

Observational Study With InnoLet® in Daily Clinical Practice

Who this might be right for
DiabetesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2
Novo Nordisk A/S 1,030
Not applicableNot Yet RecruitingNCT07169786
What this trial is testing

Diet and Progression of CKD in Patients With Type 2 Diabetes Mellitus

Who this might be right for
CKD Stage 1-4Diet Pattern AnalysisType2 Diabetes Mellitus
Mariam Emeel Haleem Naseem 160
Testing effectiveness (Phase 2)Study completedNCT04150107
What this trial is testing

Compare ORMD-0801 Once Daily to ORMD-0801 Three Times Daily in Subjects With Type 1 Diabetes

Who this might be right for
Type 1 Diabetes
Oramed, Ltd. 30
Not applicableLooking for participantsNCT06875167
What this trial is testing

Semi-closed Loop Automated Insulin Therapy in the Pediatric Population Aged 2-6 Years With Type 1 Diabetes: Impact on Quality of Life and Glycemic Control

Who this might be right for
Type 1 DiabetesClosed LoopInsulin+2 more
Fondation Lenval 20
Not applicableWithdrawnNCT02733211
What this trial is testing

Cross-over Study to Evaluate the Safety and Efficacy of Night Closed-loop Control Using the MD-Logic Automated Insulin Delivery System Compared to Sensor Augmented Pump Therapy in Poorly Controlled Patients With Type 1 Diabetes

Who this might be right for
Type 1 Diabetes
Rabin Medical Center
Testing effectiveness (Phase 2)Ended earlyNCT04899271
What this trial is testing

Assess Efficacy/Safety of Ladarixin in Type 1 Diabetes Patients With Preserved ß-cell Function at Baseline.

Who this might be right for
New-onset Type 1 Diabetes
Dompé Farmaceutici S.p.A 25
Early research (Phase 1)Study completedNCT03170544
What this trial is testing

Single Ascending Dose Study of MK-1092 in Healthy Participants and in Participants With Type 1 and Type 2 Diabetes Mellitus (MK-1092-001)

Who this might be right for
Type 1 Diabetes MellitusType 2 Diabetes Mellitus
Merck Sharp & Dohme LLC 69
Testing effectiveness (Phase 2)Active Not RecruitingNCT05743244
What this trial is testing

Janus Kinase (JAK) Inhibitors to Preserve C-Peptide Production in New Onset Type 1 Diabetes (T1D)

Who this might be right for
Diabetes Mellitus, Type 1
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 78
Not applicableStudy completedNCT04378114
What this trial is testing

Impact of Acetaminophen on Performance of Guardian™ Sensor (3) in Adults

Who this might be right for
Type 1 Diabetes MellitusType 2 Diabetes Mellitus
Medtronic MiniMed, Inc. 104
Testing effectiveness (Phase 2)Study completedNCT00406458
What this trial is testing

Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy

Who this might be right for
Diabetes Mellitus, Type 1Diabetes Mellitus, Type 2Diabetic Polyneuropathy
Sangamo Therapeutics 110
Testing effectiveness (Phase 2)Looking for participantsNCT05824975
What this trial is testing

Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)

Who this might be right for
Advanced Solid TumorMetastatic Solid TumorSoft Tissue Sarcoma (STS)+6 more
GI Innovation, Inc. 358
Early research (Phase 1)Study completedNCT01680328
What this trial is testing

Investigation of Pain During Subcutaneous Injections With Different Injection Speed and Volume Combinations

Who this might be right for
DiabetesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2+1 more
Novo Nordisk A/S 82
Very early researchUnknownNCT04690270
What this trial is testing

Sumatriptan and Glucose

Who this might be right for
Overweight
Cambridge University Hospitals NHS Foundation Trust 12
Not applicableActive Not RecruitingNCT05705869
What this trial is testing

Targeted Assessment in High-Risk paTients With dIAbetes to ideNtify Undiagnosed Heart Failure

Who this might be right for
Heart FailureDiabetes MellitusType 1 Diabetes+2 more
NHS Greater Glasgow and Clyde 706
Early research (Phase 1)Study completedNCT02536859
What this trial is testing

Comparing Pharmacodynamic and Pharmacokinetic Properties of Insulin Degludec and Insulin Glargine 300 U/mL at Steady-state Conditions in Subjects With Type 1 Diabetes Mellitus

Who this might be right for
DiabetesDiabetes Mellitus, Type 1
Novo Nordisk A/S 60
Not applicableNot Yet RecruitingNCT07802327
What this trial is testing

PMCF Study of GX-01S CGM in Adults With Diabetes

Who this might be right for
Diabetes MellitusDiabetes Mellitus ( Type 1 and Type 2)
MicroTech Medical（Hangzhou）Co.,Ltd. 100
Not applicableStudy completedNCT01194479
What this trial is testing

Effect of Formoterol on the Counterregulatory Hormonal Response to Hypoglycemia in Type 1 Diabetes.

Who this might be right for
Type 1 Diabetes
Yale University 14
Next Page